6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
52m ago	Pinnacle Silver and Gold Commences Trading on OTCQB
53m ago	Apogee Minerals Announces Non-Brokered Private Placement Financing
53m ago	Honey Badger Silver Closes Transformative Acquisition of the Important PC Silver Project in the Northwest Territories
53m ago	Mayfair Gold Provides Update on Project Work in the First Quarter of 2026 Advancing and Derisking the Fenn-Gib Gold Project
53m ago	Faraday Future Strategically Launches Its Embodied AI Developer Platform Purpose-Built for AI Natives, Marking 2026 as the Inaugural Year of EAI Robotics Education

About

Agios Pharm (NASDAQ:AGIO) — investor relations, events, news, and company updates on 6ix.

Latest News

Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET

Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA

Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in the United Arab Emirates

Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET

Financials

Revenue

$54.03 M

Market Cap

$2.06 B

EPS

-7.12

Community Chat

Ask AI